Inventor · disambiguated record
Laura Rutitzky
Also filed as: RUTITZKY LAURA
7 granted patents·7 pending applications·29 citations·filing 2014–2024
81Inventor score
Files withMOMENTA PHARMACEUTICALS INC14
Top patents by PatentIndex Score
14 records- 0192US11155640B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Oct 26, 2021·6 cites·2 claims
- 0292US11124573B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2019·Granted Sep 21, 2021·6 cites·40 claims
- 0392US10239944B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2016·Granted Mar 26, 2019·13 cites·24 claims
- 0486US11661456B2Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2018·Granted May 30, 2023·4 cites·4 claims
- 0584US2025011432A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc CONSTRUCTSMOMENTA PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0676US2024052040A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 0774US12297291B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2021·Granted May 13, 2025·0 cites·3 claims
- 0874US12071482B2Compositions and methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2021·Granted Aug 27, 2024·0 cites·13 claims
- 0965US2020087402A1Sialylated GlycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1061US2016257754A1Sialylated glycoproteinsMOMENTA PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1148US2022064298A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CTLA-4MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1248US2021147549A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO PD-L1MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1344US2025346676A1COMPOSITIONS AND METHODS RELATED TO ENGINEERED Fc-ANTIGEN BINDING DOMAIN CONSTRUCTS TARGETED TO CCR4MOMENTA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1440US12391759B2Methods related to engineered Fc constructsMOMENTA PHARMACEUTICALS INC·Filed 2017·Granted Aug 19, 2025·0 cites·3 claims
Join the waitlist — get patent alerts
Get an alert when Laura Rutitzky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →